Lv41
550 积分 2023-03-27 加入
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
26天前
已完结
In vivo site-specific engineering to reprogram T cells
1个月前
已完结
Recent advances in therapeutic cancer vaccines
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
1个月前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
1个月前
已完结
BNT162b vaccines protect rhesus macaques from SARS-CoV-2
1个月前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell-engaging bispecific antibody targeting human claudin 6
1个月前
已关闭
A systemic evaluation of the effect of dsRNA contamination on mRNA vaccine expression and immunogenicity
1个月前
已完结
N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice
1个月前
已完结
皖公网安备34019202002308
